Quince Therapeutics, Inc. — Form D

Quince Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-05. The offering totals $15.9M, of which $7.9M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
CASEY LYNCHDirectorBOISE, ID
CASEY LYNCHExecutive OfficerBOISE, ID
Una RyanDirectorSouth San Francisco, CA
David LamondDirectorSouth San Francisco, CA
David LamondRelated PersonSouth San Francisco, CA
Christopher SennerDirectorSouth San Francisco, CA
Christopher SennerRelated PersonSouth San Francisco, CA
Charles RyanExecutive OfficerSouth San Francisco, CA
Charles RyanRelated PersonSouth San Francisco, CA
Margi McLoughlinDirectorSouth San Francisco, CA
June BrayDirectorSouth San Francisco, CA
June BrayRelated PersonSouth San Francisco, CA
Luca BenattiDirectorSouth San Francisco, CA
Brendan HannahExecutive OfficerSouth San Francisco, CA
Brendan HannahRelated PersonSouth San Francisco, CA
Dirk ThyeDirectorSouth San Francisco, CA
Dirk ThyeExecutive OfficerSouth San Francisco, CA
Dirk ThyeRelated PersonSouth San Francisco, CA
Rajiv PatniDirectorSouth San Francisco, CA
Ilan ZipkinDirectorOAKLAND, CA
Roger QuyDirectorSouth San Francisco, CA
Kristen GafricExecutive OfficerSouth San Francisco, CA
Stephen DominyDirectorNOVATO, CA
Stephen A DominyDirectorSouth San Francisco, CA
Ilan A ZipkinDirectorBelmont, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2026-06-11D$186.4M$114.7M
2026-06-11D$7.4M
2025-07-01D$21.9M$11.5M
2018-05-31D$85.6M$84.5M
2017-02-14D$8.0M$7.6M

More